Newsletter Signup
Enter your email to receive our newsletter and get more stories like this directly to your inbox:

If you have not previously registered with a Euromoney group website please tick below so that we can keep you updated about Institutional Investor and other Euromoney group company products and services by:

Email

Telephone

SMS

Mail

You can also visit our preference centre and make more specific selections based on your interests. Of course, you can unsubscribe at any time.

If you have previously registered with a Euromoney group website and wish to update your marketing preferences, then please visit our preference centre to do so.

Morning Brief: ValueAct Boosts Stake in KKR

ValueAct Capital bought another 2.2 million shares or so of private equity giant KKR, boosting its stake to 9.9 percent. It paid between $19.13 and $19.50 per share between November 13 and November 28. At a conference in late April, ValueAct president Mason Morfit said the stock was worth closer to $37 per share. In an August regulatory filing, ValueAct said it had discussions with officers and directors of KKR and anticipates holding future talks about a variety of topics.

___

In a separate filing, ValueAct said it sold nearly 4 million shares of CBRE, the commercial real estate giant. This cut its stake to 7.3 percent. The hedge fund firm sold its shares for between $42.25 and $42 88 per share.

___

Viking Global Investors said it owns a little more than 6.6 million shares of Jianpu Technology, or 9.6 percent of the Chinese online financial firm that went public in mid-November. We earlier reported that Dan Och’s Och-Ziff Capital Management disclosed it scooped up 2.5 million shares of Jianpu.

___

Shares of popular hedge fund stock Micron Technology continue to tumble, dropping another 3.10 percent on Thursday, to close at $42.39. The stock is now down nearly 15 percent this week alone. Still, it is up about 93 percent for the year.

___

Shares of Horizon Pharma jumped 4.4 percent, to $14.38, after UBS raised its price target on the stock from $16 to $20. At the end of the third quarter, Deerfield Management and Paulson & Co. were among the company’s top ten shareholders.